Optic Nerve Disorders Treatment Market: Introduction According to the report, the optic nerve disorders treatment market was valued at approximately ~US$ 14.1 Bn in 2018. It is expected to expand at a CAGR of ~4% during the forecast period from 2019 to 2027. Optic nerve disorders treatment comprise medications and surgery, which treat optic nerve disorders (glaucoma, optic neuritis, and other related disorders). The optic nerve is a bundle of more than 1 million nerve fibers that carry visual messages. Damage to an optic nerve can cause vision loss depending on severity of damage to the optic nerve. Optic nerve disorders are a group of disorders related to optic nerves caused due to damage to optic nerves, which can lead to vision loss or eventually complete blindness. Growth of the optic nerve disorders treatment market can be ascribed to increase in prevalence of optic nerve disorders and other related eye disorders across the globe. North America dominated the optic nerve disorders treatment market in 2018 and is projected to continue its dominance during the forecast period, owing to the rise in the number of prescriptions for glaucoma treatment in the region and high prevalence of optic nerve disorders. Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php? flag=B&rep_id=68075 Rise in Prevalence of Eye Disorders in Geriatric Population to Drive Optic Nerve Disorders Treatment Market Growing prevalence of different eye disorders, which are rising due to optic nerve damage is a major factor responsible for the growth of the optic nerve disorders treatment market. Rise in aging population, which is more prone to ophthalmic problems, such as low sight vision is also a prime factor responsible for the expansion of the optic nerve disorders treatment market. According to National Institutes of Health, population aged 65 and above in the U.S. is projected to nearly double in the next three decades, from 48 million to 88 million by 2050. Moreover, high adoption rate of digital devices is also fueling the expansion of the optic nerve disorders treatment market due to adverse impact on vision. High Demand for Pharmacological Treatment In terms of treatment type, the optic nerve disorders treatment market has been bifurcated into pharmacological treatment and surgery. Pharmacological treatment dominated the optic nerve disorders treatment market in 2018. This segment is expected to dominate during the forecast period due to low cost and better efficacy of different medications. The pharmacological treatment segment has been further divided into prostaglandins, beta interferons, beta blockers, alpha-adrenergic agonist, carbonic anhydrase inhibitors, corticosteroids, combination drugs, and others. Prostaglandins accounted for a major share of the pharmacological treatment segment. Rise in demand for prostaglandins as a first line treatment option in glaucoma and increase in the number of prescriptions of this class are some of the major factors impacting the prostaglandins segment. Request for Analysis of COVID-19 Impact on Optic Nerve Disorders Treatment Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=68075 Glaucoma to be a Major Indication
Optic Nerve Disorders Treatment Market to Witness Comprehensive Growth by 2027
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.